OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation
Alice Fletcher, Dean Clift, Emma de Vries, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 19

Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders
Panrui Lu, Y. Cheng, Lei Xue, et al.
Cell (2024)
Closed Access | Times Cited: 16

Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes
Jonathan D. Taylor, Nathalie Barrett, Sergio Martínez Cuesta, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8

Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders
Anaïs Cornebois, Marie Sorbara, Margot Cristol, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109802-109802
Open Access | Times Cited: 4

Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access

Structural, Biological, and Biomedical Implications of mRNA Interactions with the Master Regulator HuR
Miriam Marty Clark, Andrew Farinha, Alan Morrison, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Closed Access

CircHOMER1 promotes silica-induced pulmonary fibrosis by binding to HuR and stabilizing NOX4 mRNA
Qiuyun Wu, Qianyi Zhang, Chunmeng Jin, et al.
Cellular Signalling (2025) Vol. 128, pp. 111638-111638
Closed Access

Designed peptide binders and nanobodies as PROTAC starting points for targeted degradation of PCNA and BCL6
Shuai Zhao, Jingwen Luo, Pingping Xu, et al.
International Journal of Biological Macromolecules (2025), pp. 142667-142667
Closed Access

A No-Brainer! The Therapeutic Potential of TRIM Proteins in Viral and Central Nervous System Diseases
Adam Hage, Marianne Janes, Sonja M. Best
Viruses (2025) Vol. 17, Iss. 4, pp. 562-562
Open Access

Synergizing Proteolysis-Targeting Chimeras and Nanoscale Exosome-Based Delivery Mechanisms for HIV and Antiviral Therapeutics
Nobendu Mukerjee, Swastika Maitra, Arabinda Ghosh, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 4, pp. 3499-3514
Closed Access | Times Cited: 3

Targeted protein degradation: current molecular targets, localization, and strategies
Dimanthi Pliatsika, Cindy Blatter, Rainer Riedl
Drug Discovery Today (2024), pp. 104178-104178
Open Access | Times Cited: 2

RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer
Vikash Singh, Amandeep Singh, A. Liu, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3502-3502
Open Access | Times Cited: 1

Proteomics of Ishikawa endometrial cancer cells: impact of liposomal backbone
Shabnam Fayezi, Amina Jasarevic, Thomas Strowitzki, et al.
BMC Research Notes (2024) Vol. 17, Iss. 1
Open Access

Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer
Tracess Smalley, Angelo Nicolaci, Kim C. Tran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top